antimicrobial resistance
HHS, Wellcome Commit $370M in New Funding for CARB-X
Founded in 2016, CARB-X supports the advancement of therapeutics, vaccines, rapid diagnostics, and devices to treat drug-resistant bacterial infections.
Gradientech Poised to Enter Antibiotic Susceptibility Testing Market With Gram-Negative Panel
Premium
The firm expects to soon obtain CE marking for the QuickMIC system to measure the susceptibility of Gram-negative bacteria to 12 antibiotics in clinical settings.
FDA Issues Clearances in April to Zeus Scientific, BioMérieux, Roche, Abbott, Others
Zeus Scientific obtained clearance for a test to detect IgG anti-nuclear antibodies and diagnose systemic rheumatic diseases such as systemic lupus erythematosus.
BioMérieux Joint Infection Panel Gets FDA De Novo Authorization
The 39-target panel runs on FilmArray systems and tests for 31 pathogens implicated in most acute joint infections as well as eight antimicrobial resistance genes.
Qualigen Acquires Majority Stake in Israel-based Diagnostics Developer NanoSynex
Qualigen expects to capitalize on synergies between its immunoassay diagnostics platform and NanoSynex's AST technology.